Please login to the form below

Not currently logged in
Email:
Password:

Astellas poaches new oncology head from Takeda

Claire Thom is named senior VP of global oncology development

Astellas Claire ThomDr Claire Thom has left her role at Takeda to join rival Japanese pharma company Astellas as senior VP of global oncology development.

Dr Thom was most recently senior VP portfolio management, drug development management and strategic business operations at Millennium, the oncology-focused subsidiary of Takeda.

She will now lead Astellas' efforts in cancer, which include prostate cancer drug Xtandi (enzalutamide) and Tarveca (erlotinib) – a lung cancer drug co-marketed by Roche.

At Millennium Dr Thom will have worked on Velcade, a drug co-developed with Johnson & Johnson (J&J) that is used in blood cancer.

"We're thrilled that Claire is joining our experienced oncology team at Astellas," said Dr Sef Kurstjens, chief medical officer of Astellas.

“We believe that her unique background and varied experience, along with her approach to leadership and management will support our mission to become a global category leader in oncology."

Prior to joining Millennium, Dr Thom served for several years at Takeda itself, including holding responsibility for the oversight and implementation of the global therapeutic area strategies for the company's oncology, urology and gynaecology franchises.

14th August 2013

From: Research, Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Are you ready for the digital health revolution?
In this edition of Delta magazine, we explore how rapid digitalization has transformed the care pathway and reveal how life science companies can succeed in the digital age....
#DemandDiversity: Can new medical publication guidelines help fix diversity in clinical trials?
Over the last 8 months, JAMA have been working on a new set of guidelines for research papers looking to publish with them, which is summarised in their latest editorial...
DATA shutterstock_1818502577-640.jpg
Empowering patients empowers results
Patient-centricity is key when it comes to creating a more flexible, efficient and modern process for clinical trials...

Infographics